24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Theilade, Simone ^a   Lajer, Maria ^a   Hansen, Tine W ^a   Joergensen, Christel ^a   Persson, Frederik ^a   Andrésdottir, Gudbjörg ^a   Reinhard, Henrik ^a   Nielsen, Stine Elkjær ^a   Lacy, Peter ^b   Williams, Bryan ^b   Rossing, Peter ^a,c,d  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ambulatory blood pressure; Brachial systolic blood pressure; Central aortic systolic pressure; Central pulse pressure; Diabetic complications; Type 1 diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALBUMINURIA; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DEVICES; DIABETIC RETINOPATHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INVASIVE MEASUREMENT; PROGNOSIS; PULSE PRESSURE; RISK; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

ADULT; AGED; ALBUMINURIA; ARTERIAL PRESSURE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; LOGISTIC MODELS; MALE; MANOMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SYSTOLE; TIME FACTORS;

EID: 84883104950     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-122     Document Type: Article

References (42)

1. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension 2011, 57(5):891-897. 10.1161/HYPERTENSIONAHA.110.162446, 21403089.
2. Parving HH. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991, 14(3):260-269. 10.2337/diacare.14.3.260, 2044441.
3. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Gudbjornsdottir S. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR). Diabet Med 2011, 28(10):1213-1220. 10.1111/j.1464-5491.2011.03342.x, 21627687.
4. Akkanen MJ, Kivela SL, Koistinen V, Sintonen H, Tuomilehto J. Inpatient care of patients with type 1 diabetes mellitus by duration of diabetes and sex: a nationwide population-based longitudinal study. Risk Manag Healthc Policy 2009, 2:55-64. 3270910, 22312208.
5. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005, 46(1):156-161. 10.1161/01.HYP.0000170138.56903.7a, 15939805.
6. Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension 2010, 55(6):1346-1351. 10.1161/HYPERTENSIONAHA.109.149336, 20385970.
7. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di BM, Devereux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008, 51(25):2432-2439. 10.1016/j.jacc.2008.03.031, 18565402.
8. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010, 31(15):1865-1871. 10.1093/eurheartj/ehq024, 20197424.
9. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?. J Hypertens 2009, 27(3):461-467. 10.1097/HJH.0b013e3283220ea4, 3178100, 19330899.
10. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 1999, 22(10):1722-1727. 10.2337/diacare.22.10.1722, 10526742.
11. Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96(1):308-315. 10.1161/01.CIR.96.1.308, 9236450.
12. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 2004, 43(2):176-181. 10.1161/01.HYP.0000111829.46090.92, 14698999.
13. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113(9):1213-1225.
14. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009, 54(4):716-723. 10.1161/HYPERTENSIONAHA.109.131466, 19667251.
15. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004, 43(1):92-99. 10.1016/j.jacc.2003.07.039, 14715189.
16. Williams B, Lacy PS, Baschiera F, Brunel P, Dusing R. Novel Description of the 24-Hour Circadian Rhythms of Brachial Versus Central Aortic Blood Pressure and the Impact of Blood Pressure Treatment in a Randomized Controlled Clinical Trial: The Ambulatory Central Aortic Pressure (AmCAP) Study. Hypertension 2013, 61(6):1168-1176. 10.1161/HYPERTENSIONAHA.111.00763, 23630950.
17. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002, 25(5):859-864. 10.2337/diacare.25.5.859, 11978681.
18. Nair D, Tan SY, Gan HW, Lim SF, Tan J, Zhu M, et al. The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults. J Hum Hypertens 2008, 22(3):220-222. 10.1038/sj.jhh.1002306, 17992251.
19. Williams B, Lacy PS, Yan P, Hwee CN, Liang C, Ting CM. Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an N-point moving average method. J Am Coll Cardiol 2011, 57(8):951-961. 10.1016/j.jacc.2010.09.054, 21329842.
20. Komori T, Eguchi K, Hoshide S, Williams B, Kario K. Comparison of wrist-type and arm-type 24-h blood pressure monitoring devices for ambulatory use. Blood Press Monit 2013, 18(1):57-62. 10.1097/MBP.0b013e32835d124f, 23263536.
21. Ott C, Haetinger S, Schneider MP, Pauschinger M, Schmieder RE. Comparison of two noninvasive devices for measurement of central systolic blood pressure with invasive measurement during cardiac catheterization. J Clin Hypertens (Greenwich) 2012, 14(9):575-579.
22. Theilade S, Hansen TW, Joergensen C, Lajer M, Rossing P. Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devices. Blood Press Monit 2013, 18(3):156-160. 10.1097/MBP.0b013e328360fb19, 23546451.
23. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003, 21(5):821-848. 10.1097/00004872-200305000-00001, 12714851.
24. Pewsner D, Juni P, Egger M, Battaglia M, Sundstrom J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007, 335(7622):711. 10.1136/bmj.39276.636354.AE, 2001078, 17726091.
25. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26(5):1553-1579. 10.2337/diacare.26.5.1553, 12716821.
26. Llaurado G, Ceperuelo-Mallafre V, Vilardell C, Simo R, Freixenet N, Vendrell J, et al. Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care 2012, 35(5):1083-1089. 10.2337/dc11-1475, 3329819, 22357186.
27. Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology 2012, 58(3):227-237. 10.1159/000334668, 22222677.
28. Delles C, Zimmerli LU, McGrane DJ, Koh-Tan CH, Pathi VL, McKay AJ, et al. Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertens 2008, 26(5):946-955. 10.1097/HJH.0b013e3282f7677c, 18398337.
29. Westerbacka J, Uosukainen A, Makimattila S, Schlenzka A, Yki-Jarvinen H. Insulin-induced decrease in large artery stiffness is impaired in uncomplicated type 1 diabetes mellitus. Hypertension 2000, 35(5):1043-1048. 10.1161/01.HYP.35.5.1043, 10818062.
30. Bouchi R, Babazono T, Mugishima M, Yoshida N, Nyumura I, Toya K, et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care 2011, 34(12):2570-2575. 10.2337/dc11-1020, 3220850, 21972413.
31. Raman R, Gupta A, Kulothungan V, Sharma T. Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic, Blood Pressure and Lipid Control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33). Curr Eye Res 2012, 37(6):513-523. 10.3109/02713683.2012.669005, 22577770.
32. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia 2011, 54(8):1977-1984. 10.1007/s00125-011-2198-1, 21638132.
33. Christensen NJ. Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects. J Clin Invest 1972, 51(4):779-787. 10.1172/JCI106872, 302191, 5014611.
34. Hilsted J, Richter E, Madsbad S, Tronier B, Christensen NJ, Hildebrandt P, et al. Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. N Engl J Med 1987, 317(7):421-426. 10.1056/NEJM198708133170705, 3614285.
35. Campbell IW, Ewing DJ, Anderton JL, Thompson JH, Horn DB, Clarke BF. Plasma renin activity in diabetic autonomic neuropathy. Eur J Clin Invest 1976, 6(5):381-385.
36. Meyer C, Milat F, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ. Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet Med 2004, 21(7):746-751. 10.1111/j.1464-5491.2004.01241.x, 15209768.
37. Zhang Y, Li Y, Ding FH, Sheng CS, Huang QF, Wang JG. Cardiac structure and function in relation to central blood pressure components in Chinese. J Hypertens 2011, 29(12):2462-2468. 10.1097/HJH.0b013e32834c1e7d, 21970937.
38. Sharman JE, Fang ZY, Haluska B, Stowasser M, Prins JB, Marwick TH. Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care 2005, 28(4):937-939. 10.2337/diacare.28.4.937, 15793202.
39. Tartiere-Kesri L, Tartiere JM, Logeart D, Beauvais F, Cohen SA. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction. J Am Coll Cardiol 2012, 59(5):455-461. 10.1016/j.jacc.2011.10.873, 22281248.
40. Reinhard H, Hansen PR, Wiinberg N, Kjaer A, Petersen CL, Winther K, et al. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients. Cardiovasc Diabetol 2012, 11:19. 10.1186/1475-2840-11-19, 3310741, 22390472.
41. Kimura T, Kitamura H, Inoue K, Kawada N, Matsui I, Nagasawa Y, et al. Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease. Clin Exp Nephrol 2011, 15(6):854-860. 10.1007/s10157-011-0522-1, 21858735.
42. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004, 22(8):1623-1630. 10.1097/01.hjh.0000125448.28861.fc, 15257187.